Key Points
Initiative caps permanent residents at 10 million by 2050.
Free movement with EU ends only if population limit breached and not reversed in two years.
Health sector warns of severe workforce shortages and longer patient wait times.
About 71% of Swiss physiotherapists hold foreign credentials, making them vulnerable to restrictions.
Switzerland votes June 14 on the SVP’s “No 10-Million Switzerland” initiative, which would cap the permanent resident population at 10 million by 2050. If passed, the measure could force the government to cancel the free movement agreement with the EU. Recent polls show opponents ahead, but the outcome remains uncertain. This decision will shape Switzerland’s labor market and economy for decades.
What the Initiative Would Do
The initiative sets a hard cap of 10 million residents by 2050. If the population hits 9.5 million before then, the government must tighten asylum rules and restrict family reunification. If the 10-million limit is breached, the government has two years to bring numbers back down. If it fails, the free movement agreement with the EU must be cancelled, which would also end all bilateral trade deals between Switzerland and the EU.
Health Sector Warns of Staff Shortages
Physioswiss and major health groups recommend a clear no to the initiative. About 71% of physiotherapists recognized in Switzerland in 2025 held foreign credentials. The health sector says a population cap would worsen staff shortages as Switzerland ages and demand for care rises. Hospitals and care homes would face longer wait times and may close entire departments without enough workers.
SVP Leadership Divided on Free Movement Cancellation
SVP politician Paolo Pamini stated that cancelling free movement would follow a yes vote. However, SVP leadership has avoided emphasizing this outcome during the campaign. The initiative text mentions free movement cancellation only in small print as a last resort. This gap between public messaging and legal text has created tension within the party.
Polls Show Tight Race
Recent surveys show opponents of the initiative ahead by a narrow margin. About 52% oppose the measure while support sits lower. The vote requires a double majority: approval from a majority of voters and a majority of the 26 cantons. The outcome remains uncertain with 10 days until the vote.
Final Thoughts
The June 14 vote will determine whether Switzerland limits population growth and risks its free movement agreement with the EU. Health groups and businesses warn of severe workforce shortages if the initiative passes. Polls show opponents ahead, but the margin is narrow.
FAQs
The government has two years to reduce the population. Failure triggers cancellation of the EU free movement agreement and all bilateral trade deals.
About 71% of Swiss physiotherapists hold foreign credentials. A population cap would worsen staff shortages as aging increases healthcare demand.
Approximately 52% of voters oppose the initiative. Approval requires both a voter majority and support from a majority of 26 cantons.
Disclaimer:
The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.
About Author

Danny Kontos
Co FounderDanny Kontos has been a stock investor since 2007 and co-founded Meyka in 2023. He keeps a small, focused portfolio and only moves when the numbers are hard to argue with. He has waited years on a single position before. Before Meyka, he ran a web hosting company and a mortgage lending platform, so he knows what a well-run business actually looks like under the hood. This article did not come from a news cycle. It came from someone who has been watching this space for a long time.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)